Navigation Links
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Date:10/1/2009

/p>

Commenting on Misonix's financial and operating results, Michael A. McManus, Jr., President and Chief Executive Officer, said, "During the fiscal year 2009 we accomplished a number of goals to increase shareholder value. During a time of challenging global economic conditions, we deemed it strategically important to focus more of our resources on growing our high gross margin medical device business. We successfully reached an agreement to sell our equity interest in Focus Surgery, Inc., in addition to receiving payment for a portion of our debt. The remaining portion will be paid in January 2010. We also sold our Ultrasonic Laboratory Products business for $3.5 million. The cash from these transactions will enable us to seek opportunities to enhance our value by adding new products, increasing our sales efforts, shorten development times and for general corporate purposes.

Our significant investment in R&D over the last few years has provided us with new medical device products that should enable us to grow more rapidly. This year we launched the SonicOne for wound cleansing and debridement and the BoneScalpel(TM) for spinal surgery. Both products are being sold into very large, multi billion dollar market segments. We introduced our own direct sales managers in the U.S. to supplement our contract sales agent network. These individuals, each with more than 15 years experience, together with our contract sales agents, are selling the SonicOne and SonaStar(TM) directly to doctors, hospitals and clinics. This sales force enables us to focus more on the customer and capture substantially more margin on the sale of our products.

To further broaden our sales footprint, we have aggressively expanded into international markets by the signing of 14 new distributors and agencies. We have also hired a new, direct manager to handle Latin American sales and distribution. We continue to work on our European distribution for the Sonabla
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind alle ... SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ 2015 ... besuchen. Diese Tagung soll dazu ... Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, die ...
(Date:12/15/2014)... 12, 2014 Research and Markets ( ... "Inferior Vena Cava (IVC) Filters - Global Trends, Estimates ... http://photos.prnewswire.com/prnh/20130307/600769 Global ... reach US$435 million by 2016. The North ... the global value while Europe ...
(Date:12/15/2014)... and HERZLIYA PITUACH, Israel , Dec. ... IMNP ) announced today that its Board of ... succeeding Dr. Daniel Teper who continues as Chief ... of Immune,s Board of Directors since 2013. Immune,s ... delighted to represent the interest of shareholders and to continue ...
Breaking Medicine Technology:Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... 15 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ... to the pivotal Phase II trial of its lead ... novo poor-risk acute myelogenous leukemia (AML). Alan Kessman, ... reached this milestone in the pivotal Phase II trial ...
... Study to Explore the Efficacy of Novel Proteasome Inhibitor ... Patients with Relapsed and Refractory Multiple Myeloma, SOUTH ... Multiple Myeloma Research Consortium (MMRC) and Proteolix, Inc. today,announced ... Phase 2,clinical trial to study Proteolix,s potent and selective ...
Cached Medicine Technology:Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4
(Date:12/17/2014)... Dr. Myo Nwe is the co-author of a ... Future” and co-founder of the Ace Medical Weight Loss Center ... a broad look at the industry of weight loss, and ... On film and in television shows, however, she says the ... aspects and played for basic laughs, which she believes impacts ...
(Date:12/17/2014)... 2014 This prestigious award is ... have made outstanding and innovative contributions to the ... of private practice physical therapy by the Private ... , On behalf of Performance Physical Therapy, Michelle ... of Performance accepted the award at the Private ...
(Date:12/17/2014)... A group of 127 scientists sent an ... reaction to a recent statement by the center that was ... derogated the efficacy of all brain exercises. , Signatories to ... of the center’s statement critical of brain exercise companies that ... overstated its case, in a document it had entitled “A ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 No matter ... been able to eradicate the head louse parasite—a common ... for parents. Each year between six and twelve million ... the Miami-based lice removal treatment company comes to the ... and environmentally friendly. With its track record of customer ...
(Date:12/17/2014)... Project Veritas is releasing a video interview ... economist and Obamacare architect Jonathan Gruber to public attention. ... interview, which is being distributed on YouTube. , During ... in the Affordable Care Act in order to hide ... dollar per year tax grab. , “President Obama promised ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... , , Central and western region facilities ... , , HARRISBURG, Pa., June 4 Over 300 ... healthcare-associated infections (HAIs) this week to the Patient Safety Authority ... western regions of the state will begin reporting by the ...
... and Technologist Symposium at TCT 2009 will examine the ... the management of the cardiovascular patient: ... decisions, Management decisions regarding patients with drug-eluting stents, Leadership, ... own health WHEN: September 21-22, 2009 ...
... available in French . , Montreal, June ... pulmonary disease, is a disease that results in severe breathing ... fourth leading killer worldwide. However the mechanisms responsible for some ... been well understood. Dr.Manuel Cosio from the McGill ...
... Recovery & Reinvestment Act, Electronic Health Records (EHR) implementation and ... Systems Corporation (NYSE: PER ) ( www.perotsystems.com ... "The Impact of The U.S. Stimulus on Healthcare IT," that ... industry. , , To access this video, please click ...
... Alaska Governor Sarah Palin, named "2009 Honoree" by the ... ), will be honored before a sold out crowd of ... on Sunday, June 7(th) at Flowerfields in St. James. , ... Long Island. Independent Group Home Living (IGHL; ...
... Ohio Children,s Hospital Association (OCHA) and its six ... Hospital Medical Center; Dayton Children,s Medical Center; Nationwide ... Cleveland; and Toledo Children,s Hospital - today released ... quality in children,s hospitals. , , OCHA ...
Cached Medicine News:Health News:Over 300 Pennsylvania Nursing Homes in Eastern Pennsylvania Begin Reporting Healthcare-Associated Infections 2Health News:Nurses: Providing angioplasty patient care in and out of the cath lab 2Health News:Investigation finds that cigarette smoking does not affect everyone in same way 2Health News:Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm 2Health News:Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm 3Health News:Alaska Governor Sarah Palin to be Honored Before Sold Out Crowd at IGHL 30(th) Anniversary Gala During First Visit to Long Island 2Health News:Ohio's Children's Hospitals Release New Results of Collaboration Aimed at Saving Children's Lives 2Health News:Ohio's Children's Hospitals Release New Results of Collaboration Aimed at Saving Children's Lives 3
... distinctive COLOR PURPLE* distinguish SAFESKIN* PURPLE ... sterile clinical procedures when an exceptionally ... designed as an alternative for individuals ... hypersensitivity to natural rubber latex proteins. ...
... Intraoperative Leg Positioner frees the OR staff to ... 2nd assistants to hold the leg, while enabling ... instead of leg positioning. The Siegel MAST Leg ... in any position required for knee surgery and ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Color: ...
... compact design makes this pipette useful ... ammonia in urine, and blood serum ... Deliver" by blowing out the last ... Color: orange Measur range: volume 2.0 ...
Medicine Products: